Evidence map›Paper›PMID 41341074›Full record

ArticleThe Lancet regional health. Europe2026

Hospital mortality, withdrawal of life-sustaining therapy decisions and early secondary brain insults for critically ill traumatic brain injury patients in England, Wales and Northern Ireland (2009-2024): an observational cohort study.

Xavier Chapalain, Olivier Huet, Kathryn M Rowan, Paul R Mouncey, Olivier Langeron, David K Menon, David A Harrison

Abstract read
In one paragraph

Article in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xavier ChapalainClinical Trials Unit, Intensive Care National Audit & Research Centre, Napier House, 24 High Holborn, WC1V 6AZ, London, United Kingdom.
Olivier HuetDepartment of Anaesthesiology and Critical Care, Brest University Hospital, Boulevard Tanguy Prigent, 29609 Brest Cedex, France.
Kathryn M RowanClinical Trials Unit, Intensive Care National Audit & Research Centre, Napier House, 24 High Holborn, WC1V 6AZ, London, United Kingdom.
Paul R MounceyClinical Trials Unit, Intensive Care National Audit & Research Centre, Napier House, 24 High Holborn, WC1V 6AZ, London, United Kingdom.
Olivier LangeronDepartment of Anaesthesiology and Critical Care, Brest University Hospital, Boulevard Tanguy Prigent, 29609 Brest Cedex, France.
David K MenonDivision of Anaesthesia, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 2QQ, United Kingdom.
David A HarrisonClinical Trials Unit, Intensive Care National Audit & Research Centre, Napier House, 24 High Holborn, WC1V 6AZ, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recent epidemiological studies reported conflicting results regarding mortality trends for traumatic brain injury (TBI) patients. Mortality trends for the critically ill TBI population, and their drivers of changes, remains understudied. Particularly, withdrawal of life-sustaining therapy (WLST) decisions were rarely evaluated concurrently. In this study, we aimed to describe hospital mortality and WLST trends over the past 15 years in England, Wales and Northern Ireland for TBI patients admitted to an intensive care unit (ICU). Methods: Observational cohort study, involving 235 adult ICUs participating in the Intensive Care National Audit & Research Centre (ICNARC) Case Mix Programme (CMP). From April 1, 2009 to March 31, 2024, all TBI patients were included. Comparator cohorts consisted of patients with trauma, sepsis, and vascular brain injury recorded in the CMP. The primary outcome was hospital mortality. The secondary outcome was the incidence of WLST decisions. We also examined the proportion of patients experiencing predefined early secondary brain insults. Findings: Of the 2,324,961 ICU admissions, we identified 45,684 unique TBI patients. Over the study period, hospital mortality for TBI patients increased from 25.6% (1021/3988) to 35.0% (1306/3727). The proportion of WLST decisions rose from 7.5% (301/4024) to 19.7% (759/3850). After adjustment for main confounders, multivariable analyses confirmed these trends. No similar trends were observed among the comparator cohorts. TBI patients were exposed to hypotension, hypocapnia, hypercapnia and hyperglycaemia in 49.8% (22,559/45,298), 29.9% (12,356/41,262), 33.6% (13,869/41,262) and 29.2% (12,127/41,505) of cases, respectively. Half of patients (50.3%, 20,747/41,265) were exposed to hypoxaemia, and this proportion increased markedly from 36.9% (1359/3684) to 61.2% (2186/3572) over time. Interpretation: For critically ill TBI patients, hospital mortality and WLST decisions rates increased over time. These findings raise important questions regarding the processes and ethical frameworks underpinning WLST decisions. Funding: UKRI, NIHR, UK Ministry of Defence, Alzheimer's Research UK, French Society of Anaesthesiology and Critical Care, Gueules Cassées Foundation, INNOVEO donation fund.

Indexed as

Cohort studyCritical care outcomesSecondary brain insultsTraumatic brain injuryWithdrawal life sustaining therapy

Identifiers

PMID41341074
PMCPMC12670143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.